Revenue scaled from $100.6B in 2024Q2 to $118.7B in 2026Q3, but operating margin compressed from 7.8% in 2024Q3 to 2.3%, indicating earnings slippage despite top-line growth.
Jbs N.V. (JBS) annual income statement — 12-year revenue, gross profit & net income history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 |
|---|
| Sales/Revenue | 380.37B | 471.14B | 416.95B | 363.82B | 383.97B | 362.5B | 270.2B | 204.52B | 181.68B | 163.17B | 170.38B | 162.91B | 120.47B |
| Revenue Growth % | -19.13% | 13% | 14.61% | -5.25% | 5.92% | 34.16% | 32.11% | 12.57% | 11.34% | -4.23% | 4.58% | 35.23% | - |
| Cost of Goods Sold | 338.31B | 410.82B | 354.18B | 324.17B | 322.93B | 294.01B | 224.99B | 172.58B | 155.34B | 139.4B | 149.07B | 140.32B | 101.8B |
| COGS % of Revenue | - | 87.2% | 84.94% | 89.1% | 84.1% | 81.11% | 83.27% | 84.38% | 85.5% | 85.43% | 87.49% | 86.13% | 84.5% |
| Gross Profit | 42.06B | 60.33B | 62.77B | 39.65B | 61.04B | 68.49B | 45.22B | 31.95B | 26.34B | 23.77B | 21.31B | 22.59B | 18.67B |
| Gross Margin % | 11.06% | 12.8% | 15.06% | 10.9% | 15.9% | 18.89% | 16.73% | 15.62% | 14.5% | 14.57% | 12.51% | 13.87% | 15.5% |
| Gross Profit Growth % | - | -3.9% | 58.32% | -35.04% | -10.87% | 51.46% | 41.54% | 21.28% | 10.8% | 11.53% | -5.65% | 20.98% | - |
| Operating Expenses | 31.18B | 37.7B | 39.01B | 34.35B | 35.75B | 35.14B | 24.77B | 18.5B | 19.18B | 17.04B | 14.73B | 13.47B | 10.48B |
| OpEx % of Revenue | - | 8% | 9.36% | 9.44% | 9.31% | 9.69% | 9.17% | 9.04% | 10.56% | 10.45% | 8.64% | 8.27% | 8.7% |
| Selling, General & Admin | 31.32B | 37.78B | 36.99B | 33.98B | 34.95B | 29.77B | 23.99B | 18.49B | 16.38B | 17.11B | 14.4B | 13.4B | 10.48B |
| SG&A % of Revenue | - | 8.02% | 8.87% | 9.34% | 9.1% | 8.21% | 8.88% | 9.04% | 9.01% | 10.49% | 8.45% | 8.23% | 8.7% |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | -4M | -78.47M | 2.02B | 368.69M | 798.25M | 5.36B | 778.1M | 5.16M | 2.8B | -69.15M | 325.27M | 66.73M | 0 |
| Operating Income | 10.88B | 22.63B | 23.76B | 5.3B | 25.29B | 33.35B | 20.45B | 13.45B | 7.16B | 6.73B | 6.58B | 9.12B | 8.19B |
| Operating Margin % | 2.86% | 4.8% | 5.7% | 1.46% | 6.59% | 9.2% | 7.57% | 6.58% | 3.94% | 4.12% | 3.86% | 5.6% | 6.8% |
| Operating Income Growth % | - | -4.78% | 348.17% | -79.04% | -24.16% | 63.09% | 52.06% | 87.9% | 6.38% | 2.18% | -27.8% | 11.37% | - |
| EBITDA | 24.2B | 35.25B | 35.72B | 15.68B | 35.35B | 42.38B | 28.29B | 19.76B | 11.96B | 11.2B | 11.09B | 12.79B | 10.74B |
| EBITDA Margin % | 6.36% | 7.48% | 8.57% | 4.31% | 9.21% | 11.69% | 10.47% | 9.66% | 6.58% | 6.86% | 6.51% | 7.85% | 8.91% |
| EBITDA Growth % | -35.6% | -1.3% | 127.81% | -55.64% | -16.59% | 49.81% | 43.14% | 65.2% | 6.81% | 1.04% | -13.33% | 19.13% | - |
| D&A (Non-Cash Add-back) | 13.32B | 12.63B | 11.95B | 10.38B | 10.05B | 9.03B | 7.84B | 6.31B | 4.8B | 4.47B | 4.5B | 3.67B | 2.55B |
| EBIT | 12.29B | 23.58B | 25.69B | 5.96B | 25.89B | 33.65B | 21.27B | 13.2B | 7.33B | 6.69B | 7.04B | 9.12B | 7.81B |
| Net Interest Income | -6.73B | -6.88B | -1.19B | -1.41B | -1.07B | -830.84M | -3.77B | -4.07B | -3.65B | -4.5B | -3.32B | -2.46B | -2.61B |
| Interest Income | 1.12B | 2.3B | 453.73M | 326.44M | 268.42M | 144.33M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 7.84B | 9.18B | 1.65B | 1.73B | 1.34B | 975.16M | 3.77B | 4.07B | 3.65B | 4.5B | 3.32B | 2.46B | 2.61B |
| Other Income/Expense | -6.44B | -8.23B | -8.94B | -6.7B | -6.5B | -5.13B | -12.19B | -5.95B | -8.26B | -5.58B | -6.29B | -1.24B | -4B |
| Pretax Income | 4.44B | 14.4B | 14.82B | -1.4B | 18.79B | 28.22B | 8.26B | 7.5B | -1.1B | 1.15B | 290.82M | 7.88B | 4.19B |
| Pretax Margin % | 1.17% | 3.06% | 3.55% | -0.38% | 4.89% | 7.78% | 3.06% | 3.67% | -0.6% | 0.71% | 0.17% | 4.84% | 3.48% |
| Income Tax | -73.9M | 2.17B | 4.12B | -668.94M | 2.17B | 6.93B | 3.61B | 1.03B | -1.31B | 126.29M | -274.26M | 2.75B | 1.79B |
| Effective Tax Rate % | -1.66% | 15.09% | 27.78% | 47.85% | 11.54% | 24.57% | 43.67% | 13.78% | 119.13% | 10.96% | -94.31% | 34.9% | 42.59% |
| Net Income | 4.17B | 11.1B | 9.62B | -1.06B | 15.85B | 21.24B | 4.6B | 6.07B | 25.2M | 534.2M | 233.56M | 4.64B | 2.04B |
| Net Margin % | 1.1% | 2.36% | 2.31% | -0.29% | 4.13% | 5.86% | 1.7% | 2.97% | 0.01% | 0.33% | 0.14% | 2.85% | 1.69% |
| Net Income Growth % | -63.67% | 15.4% | 1006.33% | -106.69% | -25.38% | 361.95% | -24.22% | 23981.78% | -95.28% | 128.72% | -94.97% | 127.91% | - |
| Net Income (Continuing) | 4.52B | 12.23B | 10.7B | -729.14M | 16.62B | 21.28B | 4.65B | 6.46B | 210.12M | 1.03B | 565.09M | 5.13B | 2.41B |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 4.42B | 4.51B | 5.59B | 3.65B | 3.46B | 3.68B | 3.42B | 2.85B | 2.3B | 1.85B | 1.14B | 1.59B | 1.77B |
| EPS (Diluted) | 4.08 | 10.41 | 0.80 | -0.48 | 7.09 | 8.58 | 1.73 | 2.28 | 0.01 | 0.19 | 0.09 | 1.60 | 0.71 |
| EPS Growth % | -40.71% | 1201.25% | 266.67% | -106.77% | -17.37% | 395.95% | -24.12% | - | -95% | 121.45% | -94.64% | 125.35% | - |
| EPS (Basic) | - | 10.41 | 0.80 | -0.48 | 7.09 | 8.58 | 1.73 | 2.28 | 0.01 | 0.19 | 0.09 | 1.60 | 0.71 |
| Diluted Shares Outstanding | 1.02B | 1.07B | 2.22B | 2.22B | 2.25B | 2.48B | 2.66B | 2.67B | 2.67B | 2.85B | 2.73B | 2.9B | 2.88B |
| Basic Shares Outstanding | 1.07B | 1.07B | 2.22B | 2.22B | 2.25B | 2.48B | 2.66B | 2.66B | 2.66B | 2.83B | 2.72B | 2.9B | 2.88B |
| Dividend Payout Ratio | - | 79.38% | 46.14% | - | 27.99% | 34.82% | 31.34% | 0.1% | 503.52% | 17.48% | 471.89% | 10.4% | 10.8% |
Quick answers to the most common questions about buying JBS stock.
For fiscal year 2025, Jbs N.V. (JBS) reported total revenue of $471.14B. This represents a 291.1% increase compared to $120.47B in 2014.
Jbs N.V. (JBS) is profitable, generating $11.10B in net income for the fiscal year ending 2025 with a net profit margin of 2.4%.
Jbs N.V. (JBS) reported an operating income of $22.63B, resulting in an operating profit margin of 4.8%. This margin reflects the operational efficiency of the business before interest and taxes.
Jbs N.V. (JBS) generated $60.33B in gross profit for the year, representing a gross profit margin of 12.8%. This demonstrates the company's core pricing power and production efficiency.
Key Metrics
Top Statement Risk
Thin margins amid high leverage
Metrics are mathematically derived from official filings.
Top-Line Growth Masking Earnings Slippage
Based on reported figures, JBS's quarterly revenue rose from $100.6B in 2024Q2 to $126.3B in 2025Q4, yet 2026Q3 operating margin compressed to 2.3%, suggesting top-line expansion is not translating into profit durability.
The revenue trajectory shows scale-driven expansion through 2025, with year-over-year growth peaking near 28% in 2025Q1 before decelerating to negative readings in 2026Q1 and 2026Q2. The sequential pattern suggests growth is increasingly dependent on volume and acquisitions rather than pricing power, which may warrant further investigation into organic versus inorganic contributions. Investors should monitor whether revenue stabilization in the latest quarters reflects a durable demand base or a cyclical trough.
Structurally Thin Gross Margin Under Pressure
Based on the reported income statement, JBS's gross margin fell from 16.5% in 2024Q3 to roughly 10.4% to 10.8% across the three 2026 quarters, indicating persistent commodity-driven cost pressure.
The gross margin compression appears consistent with a high variable cost base dominated by livestock and feed grain procurement, leaving limited buffer when input costs rise faster than wholesale protein prices. The contraction suggests a weakening crush spread rather than a one-time disruption, though the data alone cannot isolate segment-level drivers. Margin recovery would likely require a visible mix shift toward value-added products, which the reported figures do not yet confirm.
Operating Deleverage Eroding Profit Conversion
As reported in the financial statements, JBS's operating margin declined from 7.8% in 2024Q3 to 2.2% to 2.5% in 2026, while SG&A remained near $9-10B per quarter, indicating weak operating leverage.
Because SG&A stayed largely fixed in dollar terms while gross profit fell, operating income has contracted disproportionately, a pattern that suggests overhead is not scaling down with volume. This points to limited cost flexibility in the corporate and distribution layer. Investors should watch whether management takes measurable SG&A action, since continued rigidity could keep operating margins compressed even if revenue stabilizes.
Volatile EPS Obscures Underlying Earnings Power
Based on reported figures, JBS posted diluted EPS of $3.00 in 2025Q3 but fell to a loss of $0.10 in 2026Q2, while net margin swung between 2.6% and -0.4%, suggesting earnings are highly sensitive to non-operating items.
The gap between operating income and net income in several quarters indicates meaningful below-the-line effects, potentially including interest expense, tax items, or biological asset revaluations that the supplied data does not decompose. Stock-based compensation is small relative to net income, so it does not explain the volatility. Normalized earnings power is therefore difficult to establish, and the 2026Q2 loss warrants further investigation before relying on any single quarter.
Leverage and Margin Compression Challenge the Thesis
Based on reported figures, a Debt/Equity ratio of 2.40 combined with a 2.3% operating margin in 2026Q3 suggests limited cushion if revenue softens further, a risk that short-sellers would likely emphasize.
Bears would argue that a high-leverage balance sheet, when paired with thin and compressing margins, leaves little room to absorb livestock cycle downturns or input cost spikes without impairing debt service. The reported earnings decline and negative EPS print in 2026Q2 may be interpreted as early evidence that the multi-protein diversification is not offsetting US beef weakness. Whether the company can refinance or reduce debt without dilution is a question the supplied data cannot resolve, and investors should monitor it closely.